Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Art serves two key roles in criminal schemes. First, it acts as a direct source of illicit income through the production of ...

A heart attack does more than block blood flow. Inside your body, it unleashes chaos. Heart cells flood with harmful oxygen ...

Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory ...

Cedars-Sinai researchers have created TY1, an experimental RNA-based drug that helps the body repair damaged DNA and restore injured tissue. The idea came from studying tiny molecular “messages” ...

Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of ...

MannKind Corporation beats Q3 estimates and sees FDA progress on ReadyFlow Autoinjector, presenting strong revenue growth potential. Learn more about MNKD stock here.

Health care professionals can have a powerful impact on labeling requirements for drugs by formally petitioning the FDA for ...

AstraZeneca’s NDA for baxdrostat accepted under US FDA Priority Review in US for patients with hard-to-control hypertension: Cambridge, UK Wednesday, December 3, 2025, 09:00 Hrs ...

What we're giving (or hoping to get) this holiday season, from little luxuries like cashmere gloves to fun and practical kids ...

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...